NCT05195814View on ClinicalTrials.gov

A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis

CompletedOBSERVATIONAL

Enrollment

141

Participants

Timeline

Start Date

November 15, 2021

Primary Completion Date

October 31, 2023

Study Completion Date

October 31, 2023

Conditions

Psoriatic Arthritis

Trial Locations (1)

10017

Pfizer, New York

Sponsors

Lead Sponsor

All Listed Sponsors

lead

Pfizer

INDUSTRY

NCT05195814 - A Study to Learn About the Study Medicine (Called Tofacitinib) in People With Psoriatic Arthritis | Biotech Hunter | Biotech Hunter